Thrombophilias and Adverse Outcomes of Pregnancy — What Should a Clinician Do?
- 7 January 1999
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 340 (1) , 50-52
- https://doi.org/10.1056/nejm199901073400110
Abstract
Approximately 1 to 5 percent of pregnant women have serious complications of pregnancy, such as severe preeclampsia, abruptio placentae, intrauterine fetal death, or severe fetal growth retardation. The rates are even higher among older women, those with preexisting vascular disease (e.g., chronic hypertension, renal disease, or type 1 diabetes mellitus), those with multiple fetuses, and those who have a history of one or more of the complications during a previous pregnancy.13 The triad of severe preeclampsia, abruptio placentae, and fetal growth retardation is an important cause of fetal death, delivery before 34 weeks of gestation, and neonatal illness and . . .Keywords
This publication has 9 references indexed in Scilit:
- Increased Frequency of Genetic Thrombophilia in Women with Complications of PregnancyNew England Journal of Medicine, 1999
- Prevention of preeclampsia: A big disappointmentAmerican Journal of Obstetrics and Gynecology, 1998
- Risk Factors for Preeclampsia, Abruptio Placentae, and Adverse Neonatal Outcomes among Women with Chronic HypertensionNew England Journal of Medicine, 1998
- Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary studyEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1998
- Effects of folic acid and vitamin B6 supplementation on women with hyperhomocysteinemia and a history of preeclampsia or fetal growth restrictionAmerican Journal of Obstetrics and Gynecology, 1998
- Low-Dose Aspirin to Prevent Preeclampsia in Women at High RiskNew England Journal of Medicine, 1998
- Hyperhomocysteinaemia and protein S deficiency in complicated pregnanciesBJOG: An International Journal of Obstetrics and Gynaecology, 1997
- Activated protein C resistance and adverse pregnancy outcomeAmerican Journal of Obstetrics and Gynecology, 1997
- Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screeningPublished by American Medical Association (AMA) ,1997